These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35845555)

  • 1. Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function.
    Chuphan C; Sukarnjanaset W; Puthanakit T; Wattanavijitkul T
    J Pediatr Pharmacol Ther; 2022; 27(5):419-427. PubMed ID: 35845555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Much Vancomycin Dose Is Enough For The MRSA Infection in Pediatric Patients With Various Degrees of Renal Function?
    Wang Y; Gao P; Zhang H; Chen Y; Niu C; Liu M; Li S; Xu Q; Ye Q
    Iran J Pharm Res; 2019; 18(2):995-1009. PubMed ID: 31531080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
    Moffett BS; Morris J; Munoz F; Arikan AA
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients.
    Shoji K; Saito J; Nakagawa H; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Momper JD; Capparelli EV; Miyairi I
    Microbiol Spectr; 2021 Oct; 9(2):e0046021. PubMed ID: 34612690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.
    Jung Y; Lee DH; Kim HS
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis.
    Yellepeddi VK; Lindley B; Radetich E; Kumar S; Bhakta Z; Leclair L; Parrot M; Young DC
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0099223. PubMed ID: 38059634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Vancomycin in the Pediatric Cardiac Surgical Population.
    Moffett BS; Resendiz K; Morris J; Akcan-Arikan A; Checchia PA
    J Pediatr Pharmacol Ther; 2019; 24(2):107-116. PubMed ID: 31019403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C.
    Lu JJ; Chen M; Lv CL; Zhang R; Lu H; Cheng DH; Tang SY; Liu TT
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):535-546. PubMed ID: 32304024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance.
    He CY; Ye PP; Liu B; Song L; van den Anker J; Zhao W
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0089721. PubMed ID: 34339268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desired vancomycin trough concentration to achieve an AUC
    Zhang T; Cheng H; Pan Z; Mi J; Dong Y; Zhang Y; Sun D; Du Q; Cheng X; Dong Y
    Basic Clin Pharmacol Toxicol; 2020 Jan; 126(1):75-85. PubMed ID: 31403243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.
    Liu Q; Huang H; Xu B; Li D; Liu M; Shaik IH; Wu X
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
    Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
    Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
    Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ
    Clin Pharmacokinet; 2009; 48(4):273-80. PubMed ID: 19492872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
    Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
    J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
    Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
    J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
    Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.